These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 29921291

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Dose optimization and endorectal balloon for internal pudendal arteries sparing in prostate SBRT.
    Jaccard M, Lamanna G, Dubouloz A, Rouzaud M, Miralbell R, Zilli T.
    Phys Med; 2019 May; 61():28-32. PubMed ID: 31151576
    [Abstract] [Full Text] [Related]

  • 3. Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial.
    Jaccard M, Zilli T, Dubouloz A, Escude L, Jorcano S, Linthout N, Bral S, Verbakel W, Bruynzeel A, Björkqvist M, Minn H, Tsvang L, Symon Z, Lencart J, Oliveira A, Ozen Z, Abacioglu U, Pérez-Moreno JM, Rubio C, Rouzaud M, Miralbell R.
    Int J Radiat Oncol Biol Phys; 2020 Nov 15; 108(4):1047-1054. PubMed ID: 32535161
    [Abstract] [Full Text] [Related]

  • 4. Rectal wall sparing effect of three different endorectal balloons in 3D conformal and IMRT prostate radiotherapy.
    van Lin EN, Hoffmann AL, van Kollenburg P, Leer JW, Visser AG.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):565-76. PubMed ID: 16168848
    [Abstract] [Full Text] [Related]

  • 5. Dosimetric and deformation effects of image-guided interventions during stereotactic body radiation therapy of the prostate using an endorectal balloon.
    Jones BL, Gan G, Diot Q, Kavanagh B, Timmerman RD, Miften M.
    Med Phys; 2012 Jun 01; 39(6):3080-8. PubMed ID: 22755693
    [Abstract] [Full Text] [Related]

  • 6. Endorectal balloon reduces anorectal doses in post-prostatectomy intensity-modulated radiotherapy.
    Smeenk RJ, van Lin EN, van Kollenburg P, McColl GM, Kunze-Busch M, Kaanders JH.
    Radiother Oncol; 2011 Dec 01; 101(3):465-70. PubMed ID: 21872953
    [Abstract] [Full Text] [Related]

  • 7. Dosimetric feasibility of stereotactic irradiation of primary prostate cancer at 5x9 Gy with a method of urethral sparing.
    Benhmida S, Beneux A, Udrescu C, Rouviere O, Horn S, Enachescu C, Lapierre A, Chapet O.
    Br J Radiol; 2021 Nov 01; 94(1127):20210142. PubMed ID: 34283647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dosimetry analyses comparing high-dose-rate brachytherapy, administered as monotherapy for localized prostate cancer, with stereotactic body radiation therapy simulated using CyberKnife.
    Fukuda S, Seo Y, Shiomi H, Yamada Y, Ogata T, Morimoto M, Konishi K, Yoshioka Y, Ogawa K.
    J Radiat Res; 2014 Nov 01; 55(6):1114-21. PubMed ID: 24957754
    [Abstract] [Full Text] [Related]

  • 11. Dosimetric impacts of endorectal balloon in CyberKnife stereotactic body radiation therapy (SBRT) for early-stage prostate cancer.
    Xiang HF, Lu HM, Efstathiou JA, Zietman AL, De Armas R, Harris K, Bloch BN, Qureshi MM, Keohan S, Hirsch AE.
    J Appl Clin Med Phys; 2017 May 01; 18(3):37-43. PubMed ID: 28407345
    [Abstract] [Full Text] [Related]

  • 12. Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer.
    Ruggieri R, Naccarato S, Stavrev P, Stavreva N, Fersino S, Giaj Levra N, Mazzola R, Mancosu P, Scorsetti M, Alongi F.
    Br J Radiol; 2015 Oct 01; 88(1054):20140736. PubMed ID: 26235142
    [Abstract] [Full Text] [Related]

  • 13. Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer.
    Outaggarts Z, Wegener D, Berger B, Zips D, Paulsen F, Bleif M, Thorwarth D, Alber M, Dohm O, Müller AC.
    Acta Oncol; 2020 Aug 01; 59(8):911-917. PubMed ID: 32436467
    [Abstract] [Full Text] [Related]

  • 14. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
    Chapet O, Udrescu C, Tanguy R, Ruffion A, Fenoglietto P, Sotton MP, Devonec M, Colombel M, Jalade P, Azria D.
    Int J Radiat Oncol Biol Phys; 2014 Feb 01; 88(2):425-32. PubMed ID: 24411613
    [Abstract] [Full Text] [Related]

  • 15. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D, Cavillon F, Lacornerie T, Touzeau C, Tresch E, Lartigau E.
    Int J Radiat Oncol Biol Phys; 2013 Feb 01; 85(2):549-54. PubMed ID: 22677369
    [Abstract] [Full Text] [Related]

  • 16. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
    Murray LJ, Lilley J, Thompson CM, Cosgrove V, Mason J, Sykes J, Franks K, Sebag-Montefiore D, Henry AM.
    Int J Radiat Oncol Biol Phys; 2014 Jun 01; 89(2):406-15. PubMed ID: 24685447
    [Abstract] [Full Text] [Related]

  • 17. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
    Kishan AU, Park SJ, King CR, Roberts K, Kupelian PA, Steinberg ML, Kamrava M.
    Br J Radiol; 2015 Jun 01; 88(1056):20150658. PubMed ID: 26463234
    [Abstract] [Full Text] [Related]

  • 18. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer.
    Kole TP, Nichols RC, Lei S, Wu B, Huh SN, Morris CG, Lee S, Tong M, Mendenhall NP, Dritschilo A, Collins SP.
    Acta Oncol; 2015 Jun 01; 54(6):825-31. PubMed ID: 25227898
    [Abstract] [Full Text] [Related]

  • 19. Biological optimization in volumetric modulated arc radiotherapy for prostate carcinoma.
    Mihaylov IB, Fatyga M, Bzdusek K, Gardner K, Moros EG.
    Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):1292-8. PubMed ID: 21570214
    [Abstract] [Full Text] [Related]

  • 20. Anal wall sparing effect of an endorectal balloon in 3D conformal and intensity-modulated prostate radiotherapy.
    Smeenk RJ, van Lin EN, van Kollenburg P, Kunze-Busch M, Kaanders JH.
    Radiother Oncol; 2009 Oct 01; 93(1):131-6. PubMed ID: 19523704
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.